E

Emergent Biosolutions
D

EBS

5.13000
USD
0.22
(4.48%)
مغلق
حجم التداول
22,847
الربح لكل سهم
0
العائد الربحي
-
P/E
-1
حجم السوق
278,748,943
أصول ذات صلة
CBOE
CBOE
6.210
(2.81%)
227.250 USD
CME
CME
3.35
(1.21%)
280.43 USD
FDS
FDS
4.74
(1.10%)
434.55 USD
ICE
ICE
2.580
(1.51%)
173.410 USD
MMC
MMC
3.210
(1.43%)
227.210 USD
MSCI
MSCI
8.77
(1.60%)
555.21 USD
NDAQ
NDAQ
2.095
(2.75%)
78.230 USD
TRV
TRV
5.97
(2.28%)
267.40 USD
المزيد
الأخبار المقالات

العنوان: Emergent Biosolutions

القطاع: Healthcare
الصناعة: Drug Manufacturers - Specialty & Generic
Emergent BioSolutions Inc offers public health products to the government and healthcare providers. The company operates across three different segments, namely Commercial, Products, and Services. The Commercial Product Segment consisting of Nasal Spray; the MCM Products Segment consisting of Anthrax-MCM products, Smallpox-MCM products and Other Products and the Services Segment consisting of Bioservices portfolio. The key revenue is generated through the commercial segment which consists of NARCAN and other commercial products.